Home/Pipeline/Universal Sarbecovirus Vaccine Antigen Design

Universal Sarbecovirus Vaccine Antigen Design

SARS-CoV-2 and related coronaviruses

ResearchActive

Key Facts

Indication
SARS-CoV-2 and related coronaviruses
Phase
Research
Status
Active
Company

About KOTAI Biotechnologies

Japanese biotech company developing an immune AI platform for antibody modeling and vaccine antigen design.

View full company profile